» Articles » PMID: 39459494

The Effect of CKD-495, Eupacidin, and Their Marker Compounds on Altered Permeability in a Postoperative Ileus Animal Model

Overview
Publisher MDPI
Specialty General Medicine
Date 2024 Oct 26
PMID 39459494
Authors
Affiliations
Soon will be listed here.
Abstract

Postoperative ileus (POI) is a delay in gastrointestinal transit following surgery that leads to various complications. There is limited understanding of its effective treatment options. CKD-495 and eupacidin are natural products licensed for treating mucosal lesions in acute and chronic gastritis; however, little is known about their effects on intestinal permeability. This study evaluated the effects of CKD-495, eupacidin, and its components (eupatilin and cinnamic acid) on intestinal permeability in an animal model of POI. Guinea pigs underwent surgical procedures and were randomly assigned to different treatment groups. Drugs were administered orally prior to surgery. Intestinal permeability, leukocyte count, and the expression of calprotectin and tight junction proteins were measured in the harvested ileum tissue. The intestinal permeability and leukocyte count were higher in the POI group than in the control group. The pre-administration of CKD-495, cinnamic acid, eupacidin, and eupatilin effectively prevented these changes in the POI model. No significant differences were observed in the expression of tight junction proteins. CKD-495, cinnamic acid, eupacidin, and eupatilin exerted protective effects against increased intestinal permeability and inflammation in an animal model of POI. These natural products have potential as therapeutic options for the treatment of POI.

References
1.
Venara A, Neunlist M, Slim K, Barbieux J, Colas P, Hamy A . Postoperative ileus: Pathophysiology, incidence, and prevention. J Visc Surg. 2016; 153(6):439-446. DOI: 10.1016/j.jviscsurg.2016.08.010. View

2.
Seo S, Lee S, Kim S, Chun H, Song G, Lee D . Efficacy and safety of CKD-495 in acute and chronic gastritis: A Phase III superiority clinical trial. Medicine (Baltimore). 2023; 102(49):e35926. PMC: 10713194. DOI: 10.1097/MD.0000000000035926. View

3.
Nageen B, Sarfraz I, Rasul A, Hussain G, Rukhsar F, Irshad S . Eupatilin: a natural pharmacologically active flavone compound with its wide range applications. J Asian Nat Prod Res. 2018; 22(1):1-16. DOI: 10.1080/10286020.2018.1492565. View

4.
Kwak D, Lee O, Lee K, Won Jun D, Lee H, Yoon B . The Effect of DA-6034 on Intestinal Permeability in an Indomethacin-Induced Small Intestinal Injury Model. Gut Liver. 2016; 10(3):406-11. PMC: 4849694. DOI: 10.5009/gnl15251. View

5.
Ruwizhi N, Aderibigbe B . Cinnamic Acid Derivatives and Their Biological Efficacy. Int J Mol Sci. 2020; 21(16). PMC: 7460980. DOI: 10.3390/ijms21165712. View